Xu Zhao

Special Key Laboratory Of Gene Detection &Therapy Of Guizhou Province
Zunyi, 563000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Retraction notice to "Icariin as an emerging candidate drug for anticancer treatment: Current status and perspective" [Biomedicine & Pharmacotherapy 157 (2023) 113991].

Retraction notice to "Icariin as an emerging candidate drug for anticancer treatment: Current status and perspective" [Biomedicine & Pharmacotherapy 157 (2023) 113991].

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: May 12, 2026

Dietary intervention & immunity: underlying mechanisms and future directions.

Dietary intervention & immunity: underlying mechanisms and future directions.

Journal: Journal of advanced research

Published: October 28, 2025

Distribution of gut microbiota across intestinal segments and their impact on human physiological and pathological processes.

Distribution of gut microbiota across intestinal segments and their impact on human physiological and pathological processes.

Journal: Cell & bioscience

Published: January 13, 2025

The landscape of ATF3 in tumors: Metabolism, expression regulation, therapy approach, and open concerns.

The landscape of ATF3 in tumors: Metabolism, expression regulation, therapy approach, and open concerns.

Journal: Pharmacological research

Published: September 30, 2024

A review of non-classical MAPK family member, MAPK4: A pivotal player in cancer development and therapeutic intervention.

A review of non-classical MAPK family member, MAPK4: A pivotal player in cancer development and therapeutic intervention.

Journal: International journal of biological macromolecules

Published: February 23, 2024

Promoter A1312C mutation leads to microRNA-7 downregulation in human non-small cell lung cancer.

Promoter A1312C mutation leads to microRNA-7 downregulation in human non-small cell lung cancer.

Journal: Cellular signalling

Published: January 02, 2024

Intestinal microbiota: A bridge between intermittent fasting and tumors.

Intestinal microbiota: A bridge between intermittent fasting and tumors.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: June 27, 2023

MicroRNA-7: A New Intervention Target for Inflammation and Related Diseases.

MicroRNA-7: A New Intervention Target for Inflammation and Related Diseases.

Journal: Biomolecules

Published: June 10, 2023

MiRNA-Based Therapies for Lung Cancer: Opportunities and Challenges?

MiRNA-Based Therapies for Lung Cancer: Opportunities and Challenges?

Journal: Biomolecules

Published: March 20, 2023

MAPK4 facilitates angiogenesis by inhibiting the ERK pathway in non-small cell lung cancer.

MAPK4 facilitates angiogenesis by inhibiting the ERK pathway in non-small cell lung cancer.

Journal: Cancer innovation

Published: March 15, 2023

Amino acid metabolism in tumor: New shine in the fog?

Amino acid metabolism in tumor: New shine in the fog?

Journal: Clinical nutrition (Edinburgh, Scotland)

Published: March 04, 2023

Optimized thyroid transcription factor-1 core promoter-driven microRNA-7 expression effectively inhibits the growth of human non-small-cell lung cancer cells.

Optimized thyroid transcription factor-1 core promoter-driven microRNA-7 expression effectively inhibits the growth of human non-small-cell lung cancer cells.

Journal: Journal of Zhejiang University. Science. B

Published: November 15, 2022

Showing 1-12 of 20

Last Updated: 09/26/2026